Table 4. Logistic regression analysis of factors associated with hepatic steatosis in patients with different BMI.
| BMI | Variables | OR | 95% C.I. | P value | |
|---|---|---|---|---|---|
| <24 kg/m2 | |||||
| Recessive Model | |||||
| PNPLA3 rs738409 genotype | |||||
| CC/CG | 1 | ||||
| GG | 3.44 | 1.824–6.500 | <0.001 | ||
| Dominant Model | |||||
| HBsAg | |||||
| Negative | 1 | ||||
| Positive | 0.42 | 0.188–0.940 | 0.04 | ||
| PNPLA3 rs738409 genotype | |||||
| CC | 1 | ||||
| GG+GC | 1.69 | 1.101–2.614 | 0.02 | ||
| 24–27 kg/m2 | |||||
| Age | |||||
| Per 1 year increase | 1.023 | 1.001–1.045 | 0.04 | ||
| Diabetes | |||||
| No | 1 | ||||
| Yes | 2.201 | 1.055–3.875 | 0.03 | ||
Note: OR: odds ratio; C.I.: confidence intervals; BMI: body mass index. PNPLA3: patatin-like phospholipase domain-containing 3; HBsAg: hepatitis B surface antigen.